celastrol methyl ester has been researched along with Mouth Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Y; Cheng, X; Gong, Y; Guo, J; He, L; Ma, Q; Yu, W; Yu, X; Zhao, Q | 1 |
| Feng, W; Li, X; Mou, Y; Wang, X; Wang, Y; Zhang, Y | 1 |
1 review(s) available for celastrol methyl ester and Mouth Neoplasms
| Article | Year |
|---|---|
The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art.
Topics: Carcinoma, Squamous Cell; Humans; Male; Mouth Neoplasms; Pentacyclic Triterpenes; Triterpenes; Tumor Microenvironment | 2022 |
1 other study(ies) available for celastrol methyl ester and Mouth Neoplasms
| Article | Year |
|---|---|
Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Pentacyclic Triterpenes; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck; Triterpenes | 2021 |